Solid international R&D strength

    Maxhealth have established a cooperative relationship with an expert team from a certain university, set up the TFOmega Global Research Institute in a certain country, established a technology development center and a pilot plant, and provided services for the company's global Omega-3,6 and other fatty acid production plants and affiliated industries. After years of technological exploration and accumulation, the research institute has broken the industry's technological monopoly and blazed a trail of industry-university-research cooperation that belongs to Meisihe. It has adopted advanced proprietary technologies such as the latest generation of molecular distillation, molecular power simulation technology TF-MDST, and the unique biological expression processing technology TF-HTST to build an industry-leading digital and intelligent platform. Provide Omega-3,6 (including EPA, DHA, DPA, etc.) products with content ranging from 30% to 98%, covering types such as ethyl ester type (EE) and triglyceride type (including r-TG, n-TG). We guarantee that our products achieve outstanding qualities such as medical-grade purity, high bioavailability, low fishy smell, and stable impurity control, providing customers with the most valuable product experience and "one-stop" technical solutions.

Research Institute

Technology Development Center

Digital Intelligence Platform

Pilot Plant Factory